期刊文献+

胺碘酮合用氯沙坦治疗房颤的临床观察 被引量:1

Effect of amiodarone plus losartan in treatment of atrial fibrillation
暂未订购
导出
摘要 36例心房颤动患者以胺碘酮加氯沙坦治疗 (观察组 ) ,6 0例单用胺碘酮治疗 (对照组 ) ,两组治疗 3周后仍房颤者均进行电复律 ,复律后继续各组的药物维持 ,随访 1年。两组药物复律及电复律的成功率均无差异 ;结果表明 ,两组药物治疗复律后1~ 12个月的窦性心律维持率亦无明显差异 ;而电击复律后 12个月时窦性心律维持率 ,观察组为 76 .0 0 % ,对照组为 4 7.6 2 %(P<0 .0 5 )。提示 。 This paper is to observe the effect of oral amiodarone plus losartan in treatment of patients with sinus rhythm atrial fibrillation(AF). Thirty six patients with AF received amiodarone plus losartan treatment were analyzed retrospectively. Sixty patients with AF received amiodarone were taken as control group. After 3 weeks, the remainder of the patients with AF in 2 groups went on to have electric cardioversion. After electric cardioversion, the patients continued drugs treatment in both groups and were followed up for 1 year. There was no marked difference in cardioversion efficacy between 2 groups with chemical cardioversion and electric cardioversion. There was no marked difference between 2 groups with chemical cardioversion in the maintenance of normal sinus rhythm after 1 12 months, but there was significant difference between 2 groups with electric cardioversion in the maintenance of normal sinus rhythm after 12 months ( P <0.05). Amiodarone plus losartan is better than amiodarone alone for AF patients received electrical cardioversion in maintaining normal sinus rhythm in a long term.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2003年第8期918-919,共2页 Academic Journal of Second Military Medical University
关键词 胺碘酮 氯沙坦 房颤 治疗 电复律 临床观察 amiodarone losartan atrial fibrillation
  • 相关文献

参考文献8

  • 1刘坤申,边树怀,夏岳,刘刚,杜荣品,李延辉,董洁.胺碘酮在心房颤动复律和预防复发中的作用[J].中国心脏起搏与心电生理杂志,2001,15(5):308-310. 被引量:38
  • 2伍伟锋,黄从新,刘唐威,李庚山.心房颤动患者心房组织血管紧张素Ⅱ受体表达的研究[J].中华心律失常学杂志,2002,6(4):211-214. 被引量:23
  • 3Wellens HJ. Pulmonary vein ablation in atrial fibrillation:hype or hope[J]? Circulation,2000,102(21):2562-2564.
  • 4Allessie MA, Konings K, Kirchhof C J, et al. Electrophysiologic mechanisms of perpetuation of atrial fibrillation[J]. Am J Cardiol, 1996,77(3) : 10A-23A.
  • 5Nakashima H,Kumagai K,Urata H,et al. Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation[J].Circulation,2000,101(22):2612-2617.
  • 6Madrid AH,Bueno MG, Rebollo JM,et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation:a prospective and randomized study[J]. Circulation, 2002,106(3) : 331-336.
  • 7Suzuki J, Iwai M, Nakagami H,et al. Role of angiotensin Ⅱ -regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation[J]. Circulation, 2002,106(7): 847-853.
  • 8Goette A,Staack T,Rocken C,et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation[J]. J Am Coll Cardiol,2000,35(6) : 1669-1677.

二级参考文献11

  • 1顾复生.心房纤颤的转律治疗[J].中国实用内科杂志,1995,15(2):80-81. 被引量:19
  • 2刘坤申 边树怀 等.胸背贴铝箔片电极板心脏复律的方法和经验[J].中国循环杂志,1998,13(2):121-121.
  • 3Van den Berg MP,Crijns HJGM, Van veldhuisen DJ,et al.Effects of lisinopril in patient with heart failure and chronic atrial fibrillation. J Card Failure, 1995,1: 355-363.
  • 4Pedersen OD,Bagger H,Kober L,et al. Trandolapril reduces the incidence of atrial fibrillation after acure myocardial infarction in patients with left ventricular dysfunction. Circulation, 1999,100: 376-380.
  • 5Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol,2000,35: 1669-1677.
  • 6Rogg H,de Gasparo M,Graedel E,et al. Angiotensin Ⅱ-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J, 1996,17:1112-1120.
  • 7Asano K, Dutcher DL, Port JD, et al. Selective downregulation of the angiotensin Ⅱ AT1-receptor subtype in failing human ventricular myocardium. Circulation, 1997,95: 11931200.
  • 8Matsubara H. Pathophysiological role of angiotensin Ⅱ type 2 receptor in cardiovascular and renal diseases. Circ Res,1998,83:1182-1191.
  • 9Goette A,Amdt M,Rocken C,et al. Regulation of angiotension Ⅱ receptor subtypes during atrial fibrillation in humans. Circulation, 2000,101: 2678-2781.
  • 10胡大一,许玉韵.心律失常药物治疗的现状与展望[J].中国实用内科杂志,1999,19(9):515-517. 被引量:46

共引文献59

同被引文献45

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部